Literature DB >> 15798893

The structure and functions of the presenilins.

N N Dewji1.   

Abstract

The presenilins (PSs) were new proteins discovered in 1995 to be involved, among other functions, in the molecular mechanisms leading to Alzheimer's disease. These proteins have been the subject of many investigations since then to elucidate their molecular structures and functions. Until now, the conclusions about PS structure have been discordant, but the 8-TM structure has been accepted by the Alzheimer's community, with the evidence for the 7-TM structure largely ignored. Here the evidence is reviewed for the 6-TM, 7-TM, 8-TM and other proposed models of PS topography and possibilities offered for the differences in interpretation of the various sets of data. The conclusion is that at this stage, the 7-TM model for cell surface PS is most likely the correct one.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798893     DOI: 10.1007/s00018-005-4566-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  33 in total

1.  Impact of Rotor Ablation in Nonparoxysmal Atrial Fibrillation Patients: Results From the Randomized OASIS Trial.

Authors:  Sanghamitra Mohanty; Carola Gianni; Prasant Mohanty; Philipp Halbfass; Tamara Metz; Chintan Trivedi; Thomas Deneke; Gery Tomassoni; Rong Bai; Amin Al-Ahmad; Shane Bailey; John David Burkhardt; G Joseph Gallinghouse; Rodney Horton; Patrick M Hranitzky; Javier E Sanchez; Luigi Di Biase; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2016-05-06       Impact factor: 24.094

2.  Box Isolation of Fibrotic Areas (BIFA): A Patient-Tailored Substrate Modification Approach for Ablation of Atrial Fibrillation.

Authors:  Hans Kottkamp; Jan Berg; Roderich Bender; Andreas Rieger; Doreen Schreiber
Journal:  J Cardiovasc Electrophysiol       Date:  2015-11-20

3.  Unexpectedly High Incidence of Stroke and Left Atrial Appendage Thrombus Formation After Electrical Isolation of the Left Atrial Appendage for the Treatment of Atrial Tachyarrhythmias.

Authors:  Andreas Rillig; Roland R Tilz; Tina Lin; Thomas Fink; Christian-H Heeger; Anita Arya; Andreas Metzner; Shibu Mathew; Erik Wissner; Hisaki Makimoto; Peter Wohlmuth; Karl-Heinz Kuck; Feifan Ouyang
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-05

Review 4.  Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review.

Authors:  Anthony G Brooks; Martin K Stiles; Julien Laborderie; Dennis H Lau; Pawel Kuklik; Nicholas J Shipp; Li-Fern Hsu; Prashanthan Sanders
Journal:  Heart Rhythm       Date:  2010-01-22       Impact factor: 6.343

5.  Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study.

Authors:  Rajeev K Pathak; Adrian Elliott; Melissa E Middeldorp; Megan Meredith; Abhinav B Mehta; Rajiv Mahajan; Jeroen M L Hendriks; Darragh Twomey; Jonathan M Kalman; Walter P Abhayaratna; Dennis H Lau; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2015-06-22       Impact factor: 24.094

6.  Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY).

Authors:  Rajeev K Pathak; Melissa E Middeldorp; Megan Meredith; Abhinav B Mehta; Rajiv Mahajan; Christopher X Wong; Darragh Twomey; Adrian D Elliott; Jonathan M Kalman; Walter P Abhayaratna; Dennis H Lau; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2015-03-16       Impact factor: 24.094

7.  Left atrial appendage: an underrecognized trigger site of atrial fibrillation.

Authors:  Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Javier Sanchez; Sanghamitra Mohanty; Rodney Horton; G Joseph Gallinghouse; Shane M Bailey; Jason D Zagrodzky; Pasquale Santangeli; Steven Hao; Richard Hongo; Salwa Beheiry; Sakis Themistoclakis; Aldo Bonso; Antonio Rossillo; Andrea Corrado; Antonio Raviele; Amin Al-Ahmad; Paul Wang; Jennifer E Cummings; Robert A Schweikert; Gemma Pelargonio; Antonio Dello Russo; Michela Casella; Pietro Santarelli; William R Lewis; Andrea Natale
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

8.  Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey.

Authors:  Nikolaos Dagres; Maria Grazia Bongiorni; Torben Bjerregaard Larsen; Antonio Hernandez-Madrid; Laurent Pison; Carina Blomström-Lundqvist
Journal:  Europace       Date:  2015-10       Impact factor: 5.214

9.  Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): design and rationale.

Authors:  Atul Verma; Prashanthan Sanders; Laurent Macle; Isabel Deisenhofer; Carlos A Morillo; Jian Chen; Chen-yang Jiang; Sabine Ernst; Roberto Mantovan
Journal:  Am Heart J       Date:  2012-07       Impact factor: 4.749

10.  First-line catheter ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation.

Authors:  Florian Straube; Uwe Dorwarth; Sonia Ammar-Busch; Timo Peter; Georg Noelker; Thomas Massa; Malte Kuniss; Niels Christian Ewertsen; Kyoung Ryul Julian Chun; Juergen Tebbenjohanns; Roland Tilz; Karl Heinz Kuck; Taoufik Ouarrak; Jochen Senges; Ellen Hoffmann
Journal:  Europace       Date:  2015-10-25       Impact factor: 5.214

View more
  5 in total

Review 1.  Assembly, maturation, and trafficking of the gamma-secretase complex in Alzheimer's disease.

Authors:  Daniel R Dries; Gang Yu
Journal:  Curr Alzheimer Res       Date:  2008-04       Impact factor: 3.498

Review 2.  BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.

Authors:  Neville Marks; Martin J Berg
Journal:  Neurochem Res       Date:  2009-09-17       Impact factor: 3.996

3.  Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce ß-amyloid in Alzheimer's disease.

Authors:  Nazneen N Dewji; S Jonathan Singer; Eliezer Masliah; Edward Rockenstein; Mihyun Kim; Martha Harber; Taylor Horwood
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

Review 4.  Chaperone signalling complexes in Alzheimer's disease.

Authors:  John Koren; Umesh K Jinwal; Daniel C Lee; Jeffrey R Jones; Cody L Shults; Amelia G Johnson; Laura J Anderson; Chad A Dickey
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

5.  Structural and Functional Determinants of gamma-Secretase, an Intramembrane Protease Implicated in Alzheimer's Disease.

Authors:  Patrick C Fraering
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.